期刊文献+

介入化疗联合放疗治疗65例原发性巨块型肝癌的临床观察 被引量:4

Combined Therapy of Interventional Chemotherapy with Three-Dimentional Conformal Radiotherapy for the Treatment of Huge Liver Cancer
在线阅读 下载PDF
导出
摘要 目的研究介入化疗联合放射治疗原发性巨块型肝癌的临床疗效及毒副作用。方法对65例患者先行介入化疗,随后行三维适形放疗。结果治疗后完全缓解15例,部分缓解35例,无变化7例,1、2、3年存活率分别为82.2%、54.5%、30.3%。治疗后部分患者出现副作用,但经处理后均能完成治疗。结论介入化疗联合放疗能提高原发性巨块型肝癌的临床疗效,延长生存期,毒副作用可耐受。 Objective To evaluate the treatment efficency and side effects of interventional chemotherapy with threedimenitonal conformal radiotherapy (3 DCRT)for the treatment of huge liver cancer. Methods 65 patients with huge liver cancer were treated with interventional therapy and 3DCRT. Results The effective rate( CR + PR) was 76. 9% ,and the survival rate of 1,2,3 years were 82. 2% ,54. 5% ,30. 3%. The main side effects and major toxicity of radiotherapy and chemotherapy were tolerated. Conclusions Intervenitonal therapy with three-dimentional conformal radiotherapy can significantly raise the effective rate and survival rate.
作者 李高峰
出处 《中南医学科学杂志》 CAS 2013年第2期151-153,共3页 Medical Science Journal of Central South China
基金 广西壮族自治区自然科学基金资助(10124001B-7)
关键词 介入化疗 放射治疗 原发性巨块型肝癌 interventional therapy three-dimenitonal conformal radiotherapy huge liver cancer
作者简介 李高峰,博士,副主任医师,硕士研究生导师,主要从事肿瘤放射治疗临床研究,E—mail:ligaofeng1000@sina.com.cn.
  • 相关文献

参考文献1

二级参考文献11

  • 1徐爱兵,苏小琴,彭春雷,吴志军,李拥军,张一心,邵冰峰,张素青,邱云芳.肝动脉化疗栓塞联合三维适形放疗治疗肝癌合并门脉癌栓的临床对照研究[J].胃肠病学和肝病学杂志,2007,16(4):323-325. 被引量:12
  • 2Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther, 2009,30:881-894.
  • 3Nishikawa H, Inuzuka T, Takeda H, et al. A case of advanced hepatocellular carcinoma with portal vein tumor thrombus refractory to epirubicin that showed marked decrease in tumor markers 'after transcatheter arterial infllsion with miriplatin. Case Rep Oncol, 2011,4:327-335.
  • 4Hashimoto Y, Wada H, Kobayashi S,et al. A long-term survival case of hepatocellular carcinoma with portal vein and inferior venacava tumor thrombi . Gan To Kagaku Ryoho, 2010,37 : 2693- 2695.
  • 5Yoshidome H, Takeuchi D, Kimura F, et al. Treatment strategy for hepatoeellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience. J Am Coil Surg, 2011,212:796-803.
  • 6Kagawa S, Yoshidome H, Kimura F, et al. Transeatheter arterial ehemoembolization prolonged survival in a patient with advanced hepatocellular carcinoma accompanied by tumor thrombus of the portal vein trunk. Gan To Kagaku Ryoho, 2010,37:2690-2692.
  • 7Miyamoto A, Nakamori S, Tsujie M, et al. Re-resection of the liver as reduction surgery for hepatocellular carcinoma. Gan To Kagaku Ryoho, 2010,37:2673-2675.
  • 8Kondo M, Morimoto M, Numata K , et al. Hepatic arterial infusion therapy with a fine powder formulation of eisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Jpn J Clin Oncol, 2011,41:69-75.
  • 9Park MK, Gwak GY, Lira do H transarterial chemoembolization et al. The efficacy of combined and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosis. Hepatogastroenterology, 2010,57 : 801-806.
  • 10Ban D, Shimada K, Yamamoto Y, et al. Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg, 2009,13 : 1921-1928.

共引文献25

同被引文献47

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部